Moving Myeloid Leukemia Drug Discovery Into the Third Dimension

The development of therapies aimed at leukemia has progressed substantially in the past years but childhood acute myeloid leukemia (AML) remains one of the most challenging cancers to treat. Genomic profiling of AML has greatly enhanced our understanding of the genetic and epigenetic landscape of th...

Full description

Bibliographic Details
Main Authors: Donna M. Cartledge Wolf, Sigrid A. Langhans
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pediatrics
Subjects:
AML
Online Access:https://www.frontiersin.org/article/10.3389/fped.2019.00314/full